As stated above, several of the identified epilepsy-associated HCN1 variants generate channels with what have been deemed ‘gain of aberrant’ function properties (Bleakley et al., 2021), implying that HCN channel blockers may be potentially helpful. The gene discussed is HCN1; the disease is epilepsy.